I-027

Interference Mix 5

100 μg/mL in methanol (each analyte), Cerilliant^®

• 别名: Qualitative Interference Mixture
• 分類程式碼代碼: 41116107
• NACRES: NA.24

属性

• 等級: analytical standard
• 形狀: liquid
• 成份: Carbamazepine, 100 μg/mL ; Levetiracetam, 100 μg/mL ; Metformin hydrochloride, 100 μg/mL (as free base); Phenobarbital, 100 μg/mL ; R(-)-Phenylephrine hydrochloride, 100 μg/mL (as free base); Phenytoin, 100 μg/mL ; Sertraline hydrochloride, 100 μg/mL (as free base); Topiramate, 100 μg/mL ; Zolpidem tartrate, 100 μg/mL ; Zonisamide, 100 μg/mL
• 包裝: ampule of 1 mL
• 製造商／商標名: Cerilliant^®
• drug control: psicótropo (Spain); Decreto Lei 15/93: Tabela IV (Portugal)
• 濃度: 100 μg/mL in methanol (each analyte)
• 技術: gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• 應用: forensics and toxicology
• 格式: single component solution
• 儲存溫度: −20°C

说明

一般說明

A multi-component solution standard of routinely monitored over-the-counter (OTC) and prescription drugs carbamazepine, metformin, sertraline, zonisamide, levetiracetam, phenobarbital, topiramate, phenytoin, zolpidem and (R)-phenylephrine. This standard is for qualitative use only in the evaluation of interferences between the mix components and target analytes of interest in a testing laboratory′s analytical methods.

法律資訊

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

安全信息

• 象形圖: GHS02,GHS06,GHS08,GHS09
• 訊號詞: Danger
• 危險聲明: H225,H301 + H311 + H331,H370,H411
• 防範說明: P210 - P273 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311
• 危險分類: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Aquatic Chronic 2 - Flam. Liq. 2 - STOT SE 1
• 標靶器官: Eyes,Central nervous system
• 儲存類別代碼: 3 - Flammable liquids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: 49.5 °F - closed cup
• 閃點（°C）: 9.7 °C - closed cup